Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Endeavor Biomedicines Inc.

Headquarters: San Diego, CA, United States of America
Year Founded: 2019
Status: Private

BioCentury | May 24, 2024
Product Development

A new view of lung fibrosis in IPF

First data to show a reduction in fibrosis in IPF patients highlight the potential of imaging endpoints
BioCentury | May 23, 2024
Product Development

Hummingbird’s dual ADC payloads deliver one-two punch to tumors

Singapore biotech aiming to overcome drug resistance by creating therapies carrying multiple payloads with orthogonal MoAs
BioCentury | May 20, 2024
Product Development

Shake-up at BIO, highlights from ASGCT, and new data in IPF and obesity: a BioCentury podcast

Details on a reorganization at the high-profile biopharma advocacy group
BioCentury | Apr 26, 2024
Finance

Venture report: Arch, Foresite $1B AI play Xaira starting with Baker lab’s de novo biologics 

Plus rounds for Rubedo, Flindr, Endeavor, SynOx and more
BioCentury | Apr 17, 2024
Management Tracks

Najat Khan leaving J&J for Recursion

Plus: Innovent hires Nageatte Ibrahim as oncology CMO, and updates from Endeavor and Vittoria
BioCentury | Mar 15, 2024
Management Tracks

CFO Jeff Trigilio leaves Cullinan

Plus: CFO Bo Kruse resigns at Y-mAbs, and updates from Endeavor, Nuclera and 4P-Pharma
BioCentury | Nov 2, 2023
Management Tracks

Sam Raha named COO at Myriad

Plus: Endeavor hires a new CMO, and updates from Jasper, Syantra, Ocuphire, Senisca and more
BioCentury | Sep 14, 2022
Management Tracks

AZ and Novartis veteran Tommasi to lead R&D at Dunad

Plus new CSOs at Atomwise and Sotio, and updates from Nine Square, Fabric and Biolojic Design
BioCentury | Feb 8, 2022
Finance

Feb. 7 Quick Takes: WuXi Biologics shares fall after landing on Commerce list

Plus mega-rounds for Endeavor, Dewpoint and updates from Koneksa, ObsEva and more
Items per page:
1 - 9 of 9